Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Invivyd Inc (IVVD)

Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 84,453
  • Shares Outstanding, K 119,961
  • Annual Sales, $ 25,380 K
  • Annual Income, $ -169,930 K
  • EBIT $ -177 M
  • EBITDA $ -174 M
  • 60-Month Beta 0.40
  • Price/Sales 3.95
  • Price/Cash Flow N/A
  • Price/Book 1.48
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.44
  • Most Recent Earnings $-0.15 on 03/20/25
  • Next Earnings Date 05/15/25 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 299.30% ( +81.57%)
  • Historical Volatility 127.56%
  • IV Percentile 55%
  • IV Rank 31.79%
  • IV High 877.55% on 11/18/24
  • IV Low 29.82% on 09/17/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 85
  • Volume Avg (30-Day) 449
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 9,790
  • Open Int (30-Day) 6,761

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.02
  • Low Estimate -0.01
  • Prior Year -0.40
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4751 +63.48%
on 04/17/25
1.0900 -28.74%
on 05/13/25
+0.3054 (+64.80%)
since 04/16/25
3-Month
0.4600 +68.85%
on 04/07/25
2.1000 -63.01%
on 02/21/25
-0.8333 (-51.76%)
since 02/14/25
52-Week
0.3546 +119.04%
on 01/30/25
2.7400 -71.65%
on 02/06/25
-1.6733 (-68.30%)
since 05/16/24

Most Recent Stories

More News
Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights

IVVD : 0.7767 (+10.33%)
Invivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine Efficacy

IVVD : 0.7767 (+10.33%)
Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

IVVD : 0.7767 (+10.33%)
Invivyd Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for Measles

IVVD : 0.7767 (+10.33%)
Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025

IVVD : 0.7767 (+10.33%)
Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank

IVVD : 0.7767 (+10.33%)
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors

IVVD : 0.7767 (+10.33%)
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

IVVD : 0.7767 (+10.33%)
Invivyd Announces Continued Neutralizing Activity of PEMGARDAâ„¢ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1

IVVD : 0.7767 (+10.33%)
The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine

For Immediate ReleaseChicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

NDLS : 0.8901 (+3.26%)
IVVD : 0.7767 (+10.33%)
APPS : 4.62 (+3.59%)
FUBO : 3.21 (+8.81%)
VNET : 6.43 (+7.35%)

Business Summary

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 0.9152
2nd Resistance Point 0.8573
1st Resistance Point 0.8170
Last Price 0.7767
1st Support Level 0.7188
2nd Support Level 0.6609
3rd Support Level 0.6206

See More

52-Week High 2.7400
Fibonacci 61.8% 1.8288
Fibonacci 50% 1.5473
Fibonacci 38.2% 1.2658
Last Price 0.7767
52-Week Low 0.3546

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar